Cytadren

Active Ingredient(s): Aminoglutethimide
FDA Approved: * October 29, 1980
Pharm Company: * NOVARTIS
Category: Cancer

Aminoglutethimide (AG), sold under the brand names Elipten, Cytadren, and Orimeten among others, is a medication which has been used in the treatment of seizures, Cushing's syndrome, breast cancer, and prostate cancer, among other indications.[2][3][4][5][6][7] It has also been used by bodybuilders, athletes, and other men for muscle-building and performance- and physique-enhancing purposes. ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.